Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production ...Middle East

PR Newswire - News

SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies, announced the grand opening of its state-of-the-art TIL manufacturing...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production )

    Apple Storegoogle play

    Also on site :

    Most viewed in News